BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33450184)

  • 1. Surgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from a single-centre, phase 2 trial.
    Cho BCJ; Donahoe L; Bradbury PA; Leighl N; Keshavjee S; Hope A; Pal P; Cabanero M; Czarnecka K; McRae K; Tsao MS; de Perrot M
    Lancet Oncol; 2021 Feb; 22(2):190-197. PubMed ID: 33450184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
    Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
    Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A feasibility study evaluating Surgery for Mesothelioma After Radiation Therapy: the "SMART" approach for resectable malignant pleural mesothelioma.
    Cho BC; Feld R; Leighl N; Opitz I; Anraku M; Tsao MS; Hwang DM; Hope A; de Perrot M
    J Thorac Oncol; 2014 Mar; 9(3):397-402. PubMed ID: 24445595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma.
    de Perrot M; Feld R; Leighl NB; Hope A; Waddell TK; Keshavjee S; Cho BC
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):468-73. PubMed ID: 26614413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemithoracic intensity modulated radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis.
    Chance WW; Rice DC; Allen PK; Tsao AS; Fontanilla HP; Liao Z; Chang JY; Tang C; Pan HY; Welsh JW; Mehran RJ; Gomez DR
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):149-56. PubMed ID: 25442335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy.
    Frick AE; Nackaerts K; Moons J; Lievens Y; Verbeken E; Lambrecht M; Coolen J; Dooms C; Vansteenkiste J; De Leyn P; Nafteux P
    Eur J Cardiothorac Surg; 2019 May; 55(5):934-941. PubMed ID: 30535191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study.
    Treasure T; Lang-Lazdunski L; Waller D; Bliss JM; Tan C; Entwisle J; Snee M; O'Brien M; Thomas G; Senan S; O'Byrne K; Kilburn LS; Spicer J; Landau D; Edwards J; Coombes G; Darlison L; Peto J;
    Lancet Oncol; 2011 Aug; 12(8):763-72. PubMed ID: 21723781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma.
    Gomez DR; Hong DS; Allen PK; Welsh JS; Mehran RJ; Tsao AS; Liao Z; Bilton SD; Komaki R; Rice DC
    J Thorac Oncol; 2013 Feb; 8(2):238-45. PubMed ID: 23247629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience of volumetric modulated arc therapy for malignant pleural mesothelioma after extrapleural pneumonectomy.
    Kimura T; Doi Y; Nakashima T; Imano N; Katsuta T; Takahashi S; Kenjo M; Ozawa S; Murakami Y; Nagata Y
    J Radiat Res; 2015 Mar; 56(2):315-24. PubMed ID: 25599996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of intensity-modulated radiotherapy following extra-pleural pneumonectomy for malignant pleural mesothelioma.
    Matsuo Y; Shibuya K; Okubo K; Ueki N; Aoyama A; Sonobe M; Nakamura M; Mizowaki T; Date H; Hiraoka M
    Acta Oncol; 2017 Jul; 56(7):957-962. PubMed ID: 28117611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma.
    Baldini EH; Richards WG; Gill RR; Goodman BM; Winfrey OK; Eisen HM; Mak RH; Chen AB; Kozono DE; Bueno R; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2015 May; 149(5):1374-81. PubMed ID: 25772281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma.
    Rice DC; Stevens CW; Correa AM; Vaporciyan AA; Tsao A; Forster KM; Walsh GL; Swisher SG; Hofstetter WL; Mehran RJ; Roth JA; Liao Z; Smythe WR
    Ann Thorac Surg; 2007 Nov; 84(5):1685-92; discussion 1692-3. PubMed ID: 17954086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of induction therapy on postoperative outcome after extrapleural pneumonectomy for malignant pleural mesothelioma: does induction-accelerated hemithoracic radiation increase the surgical risk?
    Mordant P; McRae K; Cho J; Keshavjee S; Waddell TK; Feld R; de Perrot M
    Eur J Cardiothorac Surg; 2016 Sep; 50(3):433-8. PubMed ID: 27005976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial.
    Van Schil PE; Baas P; Gaafar R; Maat AP; Van de Pol M; Hasan B; Klomp HM; Abdelrahman AM; Welch J; van Meerbeeck JP;
    Eur Respir J; 2010 Dec; 36(6):1362-9. PubMed ID: 20525721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity modulated radiation therapy after extra-pleural pneumonectomy for malignant pleural mesothelioma is feasible without fatal pulmonary toxicity and provides good survival.
    Jhavar S; Pruszynski J; Gowan A; Boyle T; Deb N; Patel M
    Asia Pac J Clin Oncol; 2018 Apr; 14(2):e88-e94. PubMed ID: 28371288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of helical tomotherapy following lung-sparing surgery in locally advanced malignant pleural mesothelioma.
    Layer JP; Fischer P; Dejonckheere CS; Sarria GR; Mispelbaum R; Hattenhauer T; Wiegreffe S; Glasmacher AR; Layer K; Nour Y; Caglayan L; Grau F; Müdder T; Köksal M; Scafa D; Giordano FA; Lopez-Pastorini A; Stoelben E; Schmeel LC; Leitzen C
    Strahlenther Onkol; 2024 Jul; 200(7):605-613. PubMed ID: 37993554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation Therapy for Malignant Pleural Mesothelioma.
    Rosenzweig KE
    Thorac Surg Clin; 2020 Nov; 30(4):473-480. PubMed ID: 33012434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of local and nodal failure in malignant pleural mesothelioma after extrapleural pneumonectomy and photon-electron radiotherapy.
    Gupta V; Krug LM; Laser B; Hudka K; Flores R; Rusch VW; Rosenzweig KE
    J Thorac Oncol; 2009 Jun; 4(6):746-50. PubMed ID: 19404212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma.
    Rice DC; Smythe WR; Liao Z; Guerrero T; Chang JY; McAleer MF; Jeter MD; Correa A; Vaporciyan AA; Liu HH; Komaki R; Forster KM; Stevens CW
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):350-7. PubMed ID: 17467922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of tomotherapy in malignant pleural mesothelioma: first clinical results].
    Giraud P; Sylvestre A; Lisbona A; Zefkili S; Bonnette P; Le Pimpec Barthes F; Michaud JL; Perigaud C; Mahé MA
    Rev Mal Respir; 2011 May; 28(5):609-17. PubMed ID: 21645831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.